COMP <GO>
AHG vs LQDT // PIOTROSKI F-SCORE QUALITY
Akso Health Group ADS (NASDAQ) VS. Liquidity Services Inc. (NASDAQ) • 15-METRIC TALLY: AHG 0
— LQDT 8
▲ PIOTROSKI F-SCORE QUALITY LEADER: LQDT
LAST: $1.33 (+2.31%) • MKT CAP: $1.14B
piotroski-score
2/9
LAST: $45.29 (+3.32%) • MKT CAP: $1.42B
piotroski-score
8/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AHG VS. LQDT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AHG | LQDT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | -0.10% | 43.80% | -43.90 | LQDT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 12.90% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 34.0x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.12% | 4.15% | -5.27 | LQDT | /fcf-yield <GO> |
| Operating Margin | -60.00% | 7.40% | -67.40 | LQDT | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 5.90% | -65.90 | LQDT | /net-margins <GO> |
| Revenue Growth (YoY) | -6.40% | 31.20% | -37.60 | LQDT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 7.56 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 2/9 | 8/9 | -6.00 | LQDT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.6 | 59.3 | -1.70 | LQDT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 42.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.14B | $1.42B | -$279.6M | LQDT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AHG REV | LQDT REV | AHG GROSS % | LQDT GROSS % | AHG FCF | LQDT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $13.8M | $476.7M | -0.1% | 43.8% | -$12.8M | $59.0M |
| FY 2024 | $14.8M | $363.3M | -1.9% | 51.0% | $1.0M | $61.3M |
| FY 2023 | $2.4M | $314.5M | — | — | $1.4M | $47.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AHG // BETA —
LQDT // BETA —